| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/02/1995 | WO1995003284A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | WO1995003281A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists |
| 02/02/1995 | WO1995003273A1 Vitamin d analogues |
| 02/02/1995 | WO1995003271A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/02/1995 | WO1995003270A1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds |
| 02/02/1995 | WO1995003054A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | WO1995003050A2 Improved nicotine lozenge and therapeutic method for smoking cessation |
| 02/02/1995 | WO1994027583A3 Apoptosis inhibitors for treating neurodegenerative diseases |
| 02/02/1995 | CA2167837A1 Vitamin d analogues |
| 02/02/1995 | CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them |
| 02/02/1995 | CA2167805A1 Methods of treating apoptosis and associated conditions |
| 02/02/1995 | CA2167410A1 Endothelin antagonists |
| 02/02/1995 | CA2167308A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2144758A1 New n,n,n',n'-tetrasubstituted-1,2-ethanediamine derivative compounds |
| 02/02/1995 | CA2144521A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 02/01/1995 | EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 02/01/1995 | EP0636623A1 Indole derivatives as 5-HT1- like agonists |
| 02/01/1995 | EP0636614A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them |
| 02/01/1995 | EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them |
| 02/01/1995 | EP0636370A1 Sustained release compositions containing morphine |
| 02/01/1995 | EP0636132A1 Substituted nitrogen containing spiro compounds for use in treating cognitive deficits |
| 02/01/1995 | EP0636129A1 Indole derivatives as 5-ht1-like agonists |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same |
| 02/01/1995 | EP0636123A1 3-ureido substituted benzodiazepin-2-ones having cholecystokinin and/or gastrin antagonistic activity and their use in therapy |
| 02/01/1995 | EP0636027A1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 02/01/1995 | EP0636024A1 Potentiation of antimicrobial effects |
| 02/01/1995 | EP0528997B1 Disulfide derivatives of mercaptoacylamino acids |
| 02/01/1995 | EP0502110B1 (hetero) 4-arylmethoxy phenyl diazole derivatives, method for preparing same, and their therapeutical applications |
| 02/01/1995 | CN1098098A 哌嗪衍生物 Piperazine derivatives |
| 02/01/1995 | CN1098095A Salt of (S)-a-phenyl-2-pyridineethanamine useful in therapy |
| 01/31/1995 | US5386034 2-(alkoxy benzothiazolinon-3yl) ethylamines |
| 01/31/1995 | US5385947 Octahydrophenanthrene derivatives |
| 01/31/1995 | US5385944 Treating or preventing disorders of melatoninergic system |
| 01/31/1995 | US5385941 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
| 01/31/1995 | US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury |
| 01/31/1995 | US5385930 Treating central nervous system disorders like anxiety and depression |
| 01/31/1995 | US5385928 Antiserotonine agent |
| 01/31/1995 | US5385921 Treatment for neurodegeneration, alzheimer's disease, huntington's chorea; antihypoxic agents, antiischemic agents |
| 01/31/1995 | US5385916 Neuroleptic agents |
| 01/31/1995 | US5385903 Pharmaceutical agent for treatment of withdrawal symptoms |
| 01/31/1995 | US5385889 Substitution of L-proline at the 7-position of the peptide hormone with a D-configuration hydroxyproline ether or thioether converts agonist into antagonist |
| 01/31/1995 | CA2129215A1 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| 01/31/1995 | CA2129214A1 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives |
| 01/26/1995 | WO1995002602A1 Imidazo(1,2-a)pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists |
| 01/26/1995 | WO1995002601A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 01/26/1995 | WO1995002595A1 Benzyloxyquinuclidines as substance p antagonists |
| 01/26/1995 | WO1995002592A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | WO1995002409A2 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 01/26/1995 | WO1995002399A1 Use of nabumetone or 6-methoxynaphthyl acetic acid for the treatment of dementia |
| 01/26/1995 | WO1994027589A3 Antidepressant dosage form |
| 01/26/1995 | CA2167313A1 N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-ht1a receptor antagonists |
| 01/26/1995 | CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 01/26/1995 | CA2167169A1 Imidazo[1,2-a]pyrazin-4-one, preparation thereof and drugs containing same |
| 01/25/1995 | EP0635505A1 4-Aryloxy- and 4-arylthiopiperidine derivatives |
| 01/25/1995 | EP0635497A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compostions containing them |
| 01/25/1995 | EP0635496A2 Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635495A2 Benzospiroalkene derivates, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635269A1 Use of N-(Pyridinyl)-1H-Indol-1-Amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
| 01/25/1995 | EP0635265A1 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/25/1995 | EP0635017A1 Indole derivatives as 5-ht1 agonists |
| 01/25/1995 | EP0635003A1 Perhydroisoindole derivatives as p substance antagonists |
| 01/25/1995 | EP0634939A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 01/25/1995 | EP0600875A4 Purification of recombinant apolipoprotein e from bacteria. |
| 01/25/1995 | EP0576619B1 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 01/25/1995 | EP0480939B1 Heterocyclic amines having central nervous system activity |
| 01/25/1995 | CN1097758A Pyrrolopyrimidines |
| 01/25/1995 | CN1097752A Benocycloheptenes, benzoxepines and benzothiepines |
| 01/25/1995 | CN1097743A 9H-imidazo|1,2-a¨benzimidazole-3-acetamide derivative and preparation and pharmaceuctical application of same |
| 01/25/1995 | CN1097740A Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 01/25/1995 | CN1097735A Derivative of fatty acid and pharmaceutical composition containg same |
| 01/25/1995 | CN1097727A Octahydrophenanthrene derivatives octahydrophenanthrenderivate |
| 01/25/1995 | CN1027506C New 2,9-disubstituted-4H-pyrido(1,2-A) pyrimidin-4-ones |
| 01/25/1995 | CN1027503C Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrohbonz|cd¨indole |
| 01/24/1995 | US5384408 Nervous system disorders such as Alzheimer*s and senility |
| 01/24/1995 | US5384330 Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 01/24/1995 | US5384327 Anticonvulsant sorbopyranose sulfamates |
| 01/24/1995 | US5384322 Nitrogen-containing bicyclic compounds and pharmaceutical compositions thereof |
| 01/24/1995 | US5384319 Aminoalkylphenyl compounds |
| 01/24/1995 | CA1334095C Aroyl urea and carbamic acid derivatives |
| 01/24/1995 | CA1334094C Benzopyran derivatives |
| 01/19/1995 | WO1995002051A2 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms |
| 01/19/1995 | WO1995001979A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | WO1995001976A1 Indoline derivatives as 5ht2c antagonists |
| 01/19/1995 | WO1995001974A1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/19/1995 | WO1995001972A1 Heme binding compounds and use thereof |
| 01/19/1995 | WO1995001968A1 Novel (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl)methylamine derivatives |
| 01/19/1995 | WO1995001967A1 Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
| 01/19/1995 | WO1995001965A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 01/19/1995 | WO1995001956A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 01/19/1995 | WO1995001802A1 Growth differentiation factor-7 |
| 01/19/1995 | WO1995001791A2 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases |
| 01/19/1995 | WO1995001789A1 Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 01/19/1995 | WO1994026891A3 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 01/19/1995 | CA2166781A1 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases |
| 01/19/1995 | CA2166629A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 01/19/1995 | CA2166624A1 Indoline derivatives as 5ht2c antagonists |